findmyKOL
Clinical trialNCT03148808CompletedPhase 1Interventional

Natural Vascular Scaffold (NVS) Therapy

SponsorAlucent BiomedicalEnrollment3Catheterization, PeripheralPeripheral Arterial DiseasePeripheral Vascular Diseases
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Ohiohealth Research Institute

    Columbus, Ohio, United States

  • Lankenau Institute for Medical Research

    Wynnewood, Pennsylvania, United States

  • Wellmont Cva Heart Institute

    Kingsport, Tennessee, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
25 May 2017
Primary completion
29 Oct 2018
Completion
29 Oct 2018
Last update posted
14 Nov 2018
Registered enrollment
3
Registry id
NCT03148808

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.